CN Patent

CN108601768A — 用于治疗老花眼的组合物

Assigned to Individual · Expires 2018-09-28 · 8y expired

What this patent protects

本发明涉及一种组合物，该组合物包含(a)毛果芸香碱或其药学上可接受的盐，(b)至少一种α‑刺激物激动剂或其药学上可接受的盐，和/或(c)至少一种非甾体抗炎剂(NSAID)或其药学上可接受的盐，其中，基于组合物的总量，(a)以低于0.40％的重量百分比存在，(b)和/或(c)以低于0.090％的重量百分比存在。

USPTO Abstract

本发明涉及一种组合物，该组合物包含(a)毛果芸香碱或其药学上可接受的盐，(b)至少一种α‑刺激物激动剂或其药学上可接受的盐，和/或(c)至少一种非甾体抗炎剂(NSAID)或其药学上可接受的盐，其中，基于组合物的总量，(a)以低于0.40％的重量百分比存在，(b)和/或(c)以低于0.090％的重量百分比存在。

Drugs covered by this patent

bromfenac-sodium (BROMFENAC SODIUM)

Patent Metadata

Patent number: CN108601768A
Jurisdiction: CN
Classification: —
Expires: 2018-09-28
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.